RxDoctor Payments Data

Gina Caputo, DO

Dermatology · Newark, DENPI 1124464201

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $11,912 of the $13,243 with a category attached, or 90.0%. It is spread thinly across 35 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations.

$13,243in general payments, 2019–2025

Across 671 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • AbbVie$2K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$845
  • Sun Pharmaceutical Industries Inc.$712
  • Incyte Corporation$691
  • UCB, Inc.$603
  • plus $6K from 29 others

What the payments were for

  • Consulting fees$1751%
  • Food & beverage$11,91290%
  • Education$1,1569%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,243 in reported general payments places this provider in the 80th percentile of 23 dermatology providers in Delaware.

See all dermatology providers in Delaware

Medicare billing

Part B allowed, 2024
$104,121
Medicare patients
385
Services billed
1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab46$167,934
Clobetasol Propionate58$3,318
Ketoconazole104$1,483
Triamcinolone Acetonide82$782
Ammonium Lactate23$517
Mometasone Furoate18$451
Nystatin19$215
Mupirocin21$145
Hydrocortisone24$124

Paid to pharmacies, not to this prescriber.

Other dermatology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →